Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
February-2023 Volume 27 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2023 Volume 27 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review

FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review)

  • Authors:
    • Xingqi Meng
    • Lixuan Peng
    • Xing Wei
    • Suyun Li
  • View Affiliations / Copyright

    Affiliations: Institute of Clinical Anatomy and Reproductive Medicine, Hengyang Medical College, South China University, Hengyang, Hunan 421001, P.R. China, Heart Research Institute, Hengyang Medical College, South China University, Hengyang, Hunan 421001, P.R. China
  • Article Number: 34
    |
    Published online on: December 20, 2022
       https://doi.org/10.3892/mmr.2022.12921
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Premature ovarian insufficiency (POI) is a common clinical disease of the reproductive system in which patients lose normal gonadal function prior to the age of 40. Common pathogenic factors include iatrogenic injury, genetics, inflammation, autoimmune, environmental and psychological factors. Patients with POI experience decreased estrogen secretion levels, ovulation disorder and infertility. POI appears frequently in clinical practice and the burden of the disease is heavy; however, the detailed pathological mechanism requires further experimental evaluation. Furthermore, there is a lack of effective treatment options. Certain causes of the pathogenesis of POI can be explained by epigenetic changes. Front fork transcription factor 3 (FOXO3) is a member of the forkhead box family of transcription factors. FOXO3 was initially considered to affect insulin/insulin growth factor signal transduction. However, the target gene range of FOXO3 includes numerous genes that affect metabolism and protein stability and are associated with aging. There is an association between decreased FOXO3 expression levels and POI. In the present review article, the role of FOXO3 in POI was evaluated, which emphasized the importance of this protein in the investigation of this disease. Moreover, the present review evaluated the evidence for the potential targets and biomarkers of FOXO3 that may be used in the treatment and diagnosis of POI.
View Figures

Figure 1

Figure 2

View References

1 

Laven JS: Primary ovarian insufficiency. Semin Reprod Med. 34:230–234. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Barros F, Carvalho F, Barros A and Dória S: Premature ovarian insufficiency: Clinical orientations for genetic testing and genetic counseling. Porto Biomed J. 5:e622020. View Article : Google Scholar : PubMed/NCBI

3 

Qin Y, Jiao X, Simpson JL and Chen ZJ: Genetics of primary ovarian insufficiency: New developments and opportunities. Hum Reprod Update. 21:787–808. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Sullivan SD, Sarrel PM and Nelson LM: Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 106:1588–1599. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Cai X, Fu H, Wang Y, Liu Q and Wang X: Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway in vitro. J Ovarian Res. 13:1362020. View Article : Google Scholar : PubMed/NCBI

6 

Katari S, Aarabi M, Kintigh A, Mann S, Yatsenko SA, Sanfilippo JS, Zeleznik AJ and Rajkovic A: Chromosomal instability in women with primary ovarian insufficiency. Hum Reprod. 33:531–538. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Lee HN and Chang EM: Primordial follicle activation as new treatment for primary ovarian insufficiency. Clin Exp Reprod Med. 46:43–49. 2019. View Article : Google Scholar : PubMed/NCBI

8 

Wang B, Mu Y, Ni F, Zhou S, Wang J, Cao Y and Ma X: Analysis of FOXO3 mutation in 114 Chinese women with premature ovarian failure. Reprod Biomed Online. 20:499–503. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Donnez J, García-Solares J and Dolmans MM: Ovarian endometriosis and fertility preservation: A challenge in 2018. Minerva Ginecol. 70:408–414. 2018.PubMed/NCBI

10 

Jin M, Yu Y and Huang H: An update on primary ovarian insufficiency. Sci China Life Sci. 55:677–686. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Day JR, David A, Barbosa MGM, Brunette MA, Cascalho M and Shikanov A: Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice. Sci Rep. 9:166142019. View Article : Google Scholar : PubMed/NCBI

12 

Cattoni A, Parissone F, Porcari I, Molinari S, Masera N, Franchi M, Cesaro S, Gaudino R, Passoni P and Balduzzi A: Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations. Blood Rev. 45:1007302021. View Article : Google Scholar : PubMed/NCBI

13 

DeWire M, Green DM, Sklar CA, Merchant TE, Wallace D, Lin T, Vern-Gross T, Kun LE, Krasin MJ, Boyett JM, et al: Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy. Pediatr Blood Cancer. 62:329–334. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Cui C, Han S, Yin H, Luo B, Shen X, Yang F, Liu Z, Zhu Q, Li D and Wang Y: FOXO3 Is expressed in ovarian tissues and acts as an apoptosis initiator in granulosa cells of chickens. Biomed Res Int. 2019:69029062019. View Article : Google Scholar : PubMed/NCBI

15 

Ou L, Wei P, Li M and Gao F: Inhibitory effect of Astragalus polysaccharide on osteoporosis in ovariectomized rats by regulating FoxO3a/Wnt signaling pathway. Acta Cir Bras. 34:e2019005022019. View Article : Google Scholar : PubMed/NCBI

16 

Elseweidy MM, El-Swefy SE, Shaheen MA, Baraka NM and Hammad SK: Effect of resveratrol and mesenchymal stem cell monotherapy and combined treatment in management of osteoporosis in ovariectomized rats: Role of SIRT1/FOXO3a and Wnt/β-catenin pathways. Arch Biochem Biophys. 703:1088562021. View Article : Google Scholar : PubMed/NCBI

17 

Choi JH, Seok J, Lim SM, Kim TH and Kim GJ: Microenvironmental changes induced by placenta-derived mesenchymal stem cells restore ovarian function in ovariectomized rats via activation of the PI3K-FOXO3 pathway. Stem Cell Res Ther. 11:4862020. View Article : Google Scholar : PubMed/NCBI

18 

Li L, Shi X, Shi Y and Wang Z: The signaling pathways involved in ovarian follicle development. Front Physiol. 12:7301962021. View Article : Google Scholar : PubMed/NCBI

19 

Jang H, Na Y, Hong K, Lee S, Moon S, Cho M, Park M, Lee OH, Chang EM, Lee DR, et al: Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27Kip1 promoter in primordial follicles. J Pineal Res. 63:2017. View Article : Google Scholar : PubMed/NCBI

20 

Tang YL, Zhou Y, Wang YP, He YH, Ding JC, Li Y and Wang CL: Ginsenoside Rg1 protects against Sca-1+ HSC/HPC cell aging by regulating the SIRT1-FOXO3 and SIRT3-SOD2 signaling pathways in a γ-ray irradiation-induced aging mice model. Exp Ther Med. 20:1245–1252. 2020. View Article : Google Scholar : PubMed/NCBI

21 

Lew R: Natural history of ovarian function including assessment of ovarian reserve and premature ovarian failure. Best Pract Res Clin Obstet Gynaecol. 55:2–13. 2019. View Article : Google Scholar : PubMed/NCBI

22 

Kirshenbaum M and Orvieto R: Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal. J Assist Reprod Genet. 36:2207–2215. 2019. View Article : Google Scholar : PubMed/NCBI

23 

Laven JSE: Genetics of menopause and primary ovarian insufficiency: Time for a paradigm shift? Semin Reprod Med. 38:256–262. 2020. View Article : Google Scholar : PubMed/NCBI

24 

Abidin Z and Treacy EP: Insights into the pathophysiology of infertility in females with classical galactosaemia. Int J Mol Sci. 20:52362019. View Article : Google Scholar : PubMed/NCBI

25 

Yang X, Zhang X, Jiao J, Zhang F, Pan Y, Wang Q, Chen Q, Cai B, Tang S, Zhou Z, et al: Rare variants in FANCA induce premature ovarian insufficiency. Hum Genet. 138:1227–1236. 2019. View Article : Google Scholar : PubMed/NCBI

26 

Jiao X, Ke H, Qin Y and Chen ZJ: Molecular genetics of premature ovarian insufficiency. Trends Endocrinol Metab. 29:795–807. 2018. View Article : Google Scholar : PubMed/NCBI

27 

Liu H, Wei X, Sha Y, Liu W, Gao H, Lin J, Li Y, Tang Y, Wang Y, Wang Y and Su Z: Whole-exome sequencing in patients with premature ovarian insufficiency: Early detection and early intervention. J Ovarian Res. 13:1142020. View Article : Google Scholar : PubMed/NCBI

28 

Leng L, Tan Y, Gong F, Hu L, Ouyang Q, Zhao Y, Lu G and Lin G: Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency. Hum Reprod. 30:737–748. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Poteet B, Ali N, Bellcross C, Sherman SL, Espinel W, Hipp H and Allen EG: The diagnostic experience of women with fragile X-associated primary ovarian insufficiency (FXPOI). J Assist Reprod Genet. Nov 30–2022.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

30 

Kline BL, Jaillard S, Bell KM, Bakhshalizadeh S, Robevska G, van den Bergen J, Dulon J, Ayers KL, Christodoulou J, Tchan MC, et al: Integral role of the mitochondrial ribosome in supporting ovarian function: MRPS7 variants in syndromic premature ovarian insufficiency. Genes (Basel). 13:21132022. View Article : Google Scholar : PubMed/NCBI

31 

Wang X, Zhang X, Dang Y, Li D, Lu G, Chan WY, Leung PCK, Zhao S, Qin Y and Chen ZJ: Long noncoding RNA HCP5 participates in premature ovarian insufficiency by transcriptionally regulating MSH5 and DNA damage repair via YB1. Nucleic Acids Res. 48:4480–4491. 2020. View Article : Google Scholar : PubMed/NCBI

32 

Miyamoto K, Araki KY, Naka K, Arai F, Takubo K, Yamazaki S, Matsuoka S, Miyamoto T, Ito K, Ohmura M, et al: Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell. 1:101–112. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Yoon SY, Kim R, Jang H, Shin DH, Lee JI, Seol D, Lee DR, Chang EM and Lee WS: Peroxisome proliferator-activated receptor gamma modulator promotes neonatal mouse primordial follicle activation in vitro. Int J Mol Sci. 21:31202020. View Article : Google Scholar : PubMed/NCBI

34 

Li J, Kawamura K, Cheng Y, Liu S, Klein C, Liu S, Duan EK and Hsueh AJ: Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci USA. 107:10280–10284. 2010. View Article : Google Scholar : PubMed/NCBI

35 

Chang EM, Lim E, Yoon S, Jeong K, Bae S, Lee DR, Yoon TK, Choi Y and Lee WS: Cisplatin induces overactivation of the dormant primordial follicle through PTEN/AKT/FOXO3a pathway which leads to loss of ovarian reserve in mice. PLoS One. 10:e01442452015. View Article : Google Scholar : PubMed/NCBI

36 

Thanatsis N, Kaponis A, Koika V, Georgopoulos NA and Decavalas GO: Reduced Foxo3a, FoxL2, and p27 mRNA expression in human ovarian tissue in premature ovarian insufficiency. Hormones (Athens). 18:409–415. 2019. View Article : Google Scholar : PubMed/NCBI

37 

Jang H, Lee OH, Lee Y, Yoon H, Chang EM, Park M, Lee JW, Hong K, Kim JO, Kim NK, et al: Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary. J Pineal Res. 60:336–347. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Hu Y, Yuan DZ, Wu Y, Yu LL, Xu LZ, Yue LM, Liu L, Xu WM, Qiao XY, Zeng RJ, et al: Bisphenol A initiates excessive premature activation of primordial follicles in mouse ovaries via the PTEN signaling pathway. Reprod Sci. 25:609–620. 2018. View Article : Google Scholar : PubMed/NCBI

39 

Huang Y, Qi T, Ma L, Li D, Li C, Lan Y, Chu K, Chen P, Xu W, Cao Y, et al: Menopausal symptoms in women with premature ovarian insufficiency: Prevalence, severity, and associated factors. Menopause. 28:529–537. 2021. View Article : Google Scholar : PubMed/NCBI

40 

Menezes C, Pravata GR, Yela DA and Benetti-Pinto CL: Women with premature ovarian failure using hormone therapy do not experience increased levels of depression, anxiety and stress compared to controls. J Affect Disord. 273:562–566. 2020. View Article : Google Scholar : PubMed/NCBI

41 

McDonald IR, Welt CK and Dwyer AA: Health-related quality of life in women with primary ovarian insufficiency: A scoping review of the literature and implications for targeted interventions. Hum Reprod. 37:2817–2830. 2022.PubMed/NCBI

42 

Al-Anati L, Kadekar S, Högberg J and Stenius U: PCB153, TCDD and estradiol compromise the benzo[a]pyrene-induced p53-response via FoxO3a. Chem Biol Interact. 219:159–167. 2014. View Article : Google Scholar : PubMed/NCBI

43 

Al-Anati L, Högberg J and Stenius U: Non-dioxin-like PCBs interact with benzo[a]pyrene-induced p53-responses and inhibit apoptosis. Toxicol Appl Pharmacol. 249:166–177. 2010. View Article : Google Scholar : PubMed/NCBI

44 

Drukteinis JS, Medrano T, Ablordeppey EA, Kitzman JM and Shiverick KT: Benzo[a]pyrene, but not 2,3,7,8-TCDD, induces G2/M cell cycle arrest, p21CIP1 and p53 phosphorylation in human choriocarcinoma JEG-3 cells: A distinct signaling pathway. Placenta. 26 (Suppl A):S87–S95. 2005. View Article : Google Scholar : PubMed/NCBI

45 

Fujiki K, Inamura H and Matsuoka M: Phosphorylation of FOXO3a by PI3K/Akt pathway in HK-2 renal proximal tubular epithelial cells exposed to cadmium. Arch Toxicol. 87:2119–2127. 2013. View Article : Google Scholar : PubMed/NCBI

46 

Polter A, Yang S, Zmijewska AA, van Groen T, Paik JH, Depinho RA, Peng SL, Jope RS and Li X: Forkhead box, class O transcription factors in brain: Regulation and behavioral manifestation. Biol Psychiatry. 65:150–159. 2009. View Article : Google Scholar : PubMed/NCBI

47 

Wang H, Quirion R, Little PJ, Cheng Y, Feng ZP, Sun HS, Xu J and Zheng W: Forkhead box O transcription factors as possible mediators in the development of major depression. Neuropharmacology. 99:527–537. 2015. View Article : Google Scholar : PubMed/NCBI

48 

Xia M, Wang X, Xu J, Qian Q, Gao M and Wang H: Tris (1-chloro-2-propyl) phosphate exposure to zebrafish causes neurodevelopmental toxicity and abnormal locomotor behavior. Sci Total Environ. 758:1436942021. View Article : Google Scholar : PubMed/NCBI

49 

Fan J, Li D, Chen HS, Huang JG, Xu JF, Zhu WW, Chen JG and Wang F: Metformin produces anxiolytic-like effects in rats by facilitating GABAA receptor trafficking to membrane. Br J Pharmacol. 176:297–316. 2019. View Article : Google Scholar : PubMed/NCBI

50 

Chen Y and Zhao R, Li X, Luan YP, Xing LW, Zhang XJ, Wang J, Xia XY and Zhao R: Preventive electroacupuncture alleviates oxidative stress and inflammation via Keap1/Nrf2/HO-1 pathway in rats with cyclophosphamide-induced premature ovarian insufficiency. Biomed Res Int. 2022:67185922022. View Article : Google Scholar : PubMed/NCBI

51 

Ma WR and Tan Y: The effect and mechanism of hyperin on ovarian reserve of tripterygium glycosides-induced POI mice. Sichuan Da Xue Xue Bao Yi Xue Ban. 52:458–466. 2021.(In Chinese). PubMed/NCBI

52 

Ding C, Qian C, Hou S, Lu J, Zou Q, Li H and Huang B: Exosomal miRNA-320a is released from hAMSCs and regulates SIRT4 to prevent reactive oxygen species generation in POI. Mol Ther Nucleic Acids. 21:37–50. 2020. View Article : Google Scholar : PubMed/NCBI

53 

Chen S, Lu Y, Chen Y, Xu J, Chen L, Zhao W, Wang T, Wang H and Wang P: The effect of Bu Shen Huo Xue Tang on autoimmune premature ovarian insufficiency via modulation of the Nrf2/Keap1 signaling pathway in mice. J Ethnopharmacol. 273:1139962021. View Article : Google Scholar : PubMed/NCBI

54 

Chen Y, Fan X, Ma K, Wang K, Tian C, Li M and Gong L: Bushen culuan decoction ameliorates premature ovarian insufficiency by acting on the Nrf2/ARE signaling pathway to alleviate oxidative stress. Front Pharmacol. 13:8579322022. View Article : Google Scholar : PubMed/NCBI

55 

You L, Wang Z, Li H, Shou J, Jing Z, Xie J, Sui X, Pan H and Han W: The role of STAT3 in autophagy. Autophagy. 11:729–739. 2015. View Article : Google Scholar : PubMed/NCBI

56 

Zhang J and Ney PA: Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 16:939–946. 2009. View Article : Google Scholar : PubMed/NCBI

57 

Das S, Mitrovsky G, Vasanthi HR and Das DK: Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN. Oxid Med Cell Longev. 2014:3451052014. View Article : Google Scholar : PubMed/NCBI

58 

Tseng AHH, Shieh SS and Wang DL: SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. Free Radic Biol Med. 63:222–234. 2013. View Article : Google Scholar : PubMed/NCBI

59 

Müller L, Di Benedetto S and Pawelec G: The immune system and its dysregulation with aging. Subcell Biochem. 91:21–43. 2019. View Article : Google Scholar : PubMed/NCBI

60 

Huang Y, Hu C, Ye H, Luo R, Fu X, Li X, Huang J, Chen W and Zheng Y: Inflamm-aging: A new mechanism affecting premature ovarian insufficiency. J Immunol Res. 2019:80698982019. View Article : Google Scholar : PubMed/NCBI

61 

He L, Wang X, Cheng D, Xiong Z and Liu X: Ginsenoside Rg1 improves pathological damages by activating the p21-p53-STK pathway in ovary and Bax-Bcl2 in the uterus in premature ovarian insufficiency mouse models. Mol Med Rep. 23:372021.PubMed/NCBI

62 

Domniz N and Meirow D: Premature ovarian insufficiency and autoimmune diseases. Best Pract Res Clin Obstet Gynaecol. 60:42–55. 2019. View Article : Google Scholar : PubMed/NCBI

63 

Lv SJ, Hou SH, Gan L and Sun J: Establishment and mechanism study of a primary ovarian insufficiency mouse model using lipopolysaccharide. Anal Cell Pathol (Amst). 2021:17815322021.PubMed/NCBI

64 

Cao Y, Chen J, Ren G, Zhang Y, Tan X and Yang L: Punicalagin prevents inflammation in LPS-induced RAW264.7 macrophages by inhibiting FoxO3a/autophagy signaling pathway. Nutrients. 11:27942019. View Article : Google Scholar : PubMed/NCBI

65 

Lu D, Song J, Sun Y, Qi F, Liu L, Jin Y, McNutt MA and Yin Y: Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders. J Autoimmun. 94:156–165. 2018. View Article : Google Scholar : PubMed/NCBI

66 

Liu N, Feng X, Wang W, Zhao X and Li X: Paeonol protects against TNF-α-induced proliferation and cytokine release of rheumatoid arthritis fibroblast-like synoviocytes by upregulating FOXO3 through inhibition of miR-155 expression. Inflamm Res. 66:603–610. 2017. View Article : Google Scholar : PubMed/NCBI

67 

Brandstetter B, Dalwigk K, Platzer A, Niederreiter B, Kartnig F, Fischer A, Vladimer GI, Byrne RA, Sevelda F, Holinka J, et al: FOXO3 is involved in the tumor necrosis factor-driven inflammatory response in fibroblast-like synoviocytes. Lab Invest. 99:648–658. 2019. View Article : Google Scholar : PubMed/NCBI

68 

Lee A, Qiao Y, Grigoriev G, Chen J, Park-Min KH, Park SH, Ivashkiv LB and Kalliolias GD: Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 65:928–938. 2013. View Article : Google Scholar : PubMed/NCBI

69 

Di Vincenzo S, Heijink IH, Noordhoek JA, Cipollina C, Siena L, Bruno A, Ferraro M, Postma DS, Gjomarkaj M and Pace E: SIRT1/FoxO3 axis alteration leads to aberrant immune responses in bronchial epithelial cells. J Cell Mol Med. 22:2272–2282. 2018. View Article : Google Scholar : PubMed/NCBI

70 

Lin Z, Niu Y, Wan A, Chen D, Liang H, Chen X, Sun L, Zhan S, Chen L, Cheng C, et al: RNA m6A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. EMBO J. 39:e1031812020. View Article : Google Scholar : PubMed/NCBI

71 

Li X, Xie J, Wang Q, Cai H, Xie C and Fu X: miR-21 and pellino-1 expression profiling in autoimmune premature ovarian insufficiency. J Immunol Res. 2020:35826482020. View Article : Google Scholar : PubMed/NCBI

72 

Sharif K, Watad A, Bridgewood C, Kanduc D, Amital H and Shoenfeld Y: Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab. 33:1013232019. View Article : Google Scholar : PubMed/NCBI

73 

Otsuka N, Tong ZB, Vanevski K, Tu W, Cheng MH and Nelson LM: Autoimmune oophoritis with multiple molecular targets mitigated by transgenic expression of mater. Endocrinology. 152:2465–2473. 2011. View Article : Google Scholar : PubMed/NCBI

74 

Hsieh YT and Ho JYP: Thyroid autoimmunity is associated with higher risk of premature ovarian insufficiency-a nationwide health insurance research database study. Hum Reprod. 36:1621–1629. 2021. View Article : Google Scholar : PubMed/NCBI

75 

Becher J, Simula L, Volpe E, Procaccini C, La Rocca C, D'Acunzo P, Cianfanelli V, Strappazzon F, Caruana I, Nazio F, et al: AMBRA1 controls regulatory T-cell differentiation and homeostasis upstream of the FOXO3-FOXP3 axis. Dev Cell. 47:592–607.e6. 2018. View Article : Google Scholar : PubMed/NCBI

76 

Deng Y, Wang F, Hughes T and Yu J: FOXOs in cancer immunity: Knowns and unknowns. Semin Cancer Biol. 50:53–64. 2018. View Article : Google Scholar : PubMed/NCBI

77 

Bouzeyen R, Haoues M, Barbouche MR, Singh R and Essafi M: FOXO3 transcription factor regulates IL-10 expression in mycobacteria-infected macrophages, tuning their polarization and the subsequent adaptive immune response. Front Immunol. 10:29222019. View Article : Google Scholar : PubMed/NCBI

78 

Klagge A, Weidinger C, Krause K, Jessnitzer B, Gutknecht M and Fuhrer D: The role of FOXO3 in DNA damage response in thyrocytes. Endocr Relat Cancer. 18:555–564. 2011. View Article : Google Scholar : PubMed/NCBI

79 

Lu M, Xu W, Gao B and Xiong S: Blunting autoantigen-induced FOXO3a protein phosphorylation and degradation is a novel pathway of glucocorticoids for the treatment of systemic lupus erythematosus. J Biol Chem. 291:19900–19912. 2016. View Article : Google Scholar : PubMed/NCBI

80 

Zhao X, Petursson F, Viollet B, Lotz M, Terkeltaub R and Liu-Bryan R: Peroxisome proliferator-activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP-activated protein kinase. Arthritis Rheumatol. 66:3073–3082. 2014. View Article : Google Scholar : PubMed/NCBI

81 

Kato M, Yuan H, Xu ZG, Lanting L, Li SL, Wang M, Hu MC, Reddy MA and Natarajan R: Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: A novel mechanism related to diabetic kidney disease. J Am Soc Nephrol. 17:3325–3335. 2006. View Article : Google Scholar : PubMed/NCBI

82 

Ock CW and Kim GD: Harmine hydrochloride mediates the induction of G2/M cell cycle arrest in breast cancer cells by regulating the MAPKs and AKT/FOXO3a signaling pathways. Molecules. 26:67142021. View Article : Google Scholar : PubMed/NCBI

83 

Wang H, Li G, Zhang J, Gao F, Li W, Qin Y and Chen ZJ: Novel WT1 missense mutations in Han Chinese women with premature ovarian failure. Sci Rep. 5:139832015. View Article : Google Scholar : PubMed/NCBI

84 

Bouali N, Francou B, Bouligand J, Lakhal B, Malek I, Kammoun M, Warszawski J, Mougou S, Saad A and Guiochon-Mantel A: NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiency. Clin Genet. 89:608–613. 2016. View Article : Google Scholar : PubMed/NCBI

85 

Turkyilmaz A, Alavanda C, Ates EA, Geckinli BB, Polat H, Gokcu M, Karakaya T, Cebi AH, Soylemez MA, Guney Aİ, et al: Whole-exome sequencing reveals new potential genes and variants in patients with premature ovarian insufficiency. J Assist Reprod Genet. 39:695–710. 2022. View Article : Google Scholar : PubMed/NCBI

86 

Morris BJ, Willcox DC, Donlon TA and Willcox BJ: FOXO3: A major gene for human longevity-a mini-review. Gerontology. 61:515–525. 2015. View Article : Google Scholar : PubMed/NCBI

87 

Morris BJ, Willcox BJ and Donlon TA: Genetic and epigenetic regulation of human aging and longevity. Biochim Biophys Acta Mol Basis Dis. 1865:1718–1744. 2019. View Article : Google Scholar : PubMed/NCBI

88 

Zhang W, Zuo M, Lu J and Wang Y: Adiponectin reduces embryonic loss rate and ameliorates trophoblast apoptosis in early pregnancy of mice with polycystic ovary syndrome by affecting the AMPK/PI3K/Akt/FoxO3a signaling pathway. Reprod Sci. 27:2232–2241. 2020. View Article : Google Scholar : PubMed/NCBI

89 

Mikaeili S, Rashidi BH, Safa M, Najafi A, Sobhani A, Asadi E and Abbasi M: Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome. Arch Gynecol Obstet. 294:185–192. 2016. View Article : Google Scholar : PubMed/NCBI

90 

Zhang S, Deng W, Liu Q, Wang P, Yang W and Ni W: Altered m6A modification is involved in up-regulated expression of FOXO3 in luteinized granulosa cells of non-obese polycystic ovary syndrome patients. J Cell Mol Med. 24:11874–11882. 2020. View Article : Google Scholar : PubMed/NCBI

91 

Salcher S, Spoden G, Hagenbuchner J, Führer S, Kaserer T, Tollinger M, Huber-Cantonati P, Gruber T, Schuster D, Gust R, et al: A drug library screen identifies carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma. Oncogene. 39:1080–1097. 2020. View Article : Google Scholar : PubMed/NCBI

92 

Dong S, Zhang K and Shi Y: Carbenoxolone has the potential to ameliorate acute incision pain in rats. Mol Med Rep. 24:5202021. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Meng X, Peng L, Wei X and Li S: FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review). Mol Med Rep 27: 34, 2023.
APA
Meng, X., Peng, L., Wei, X., & Li, S. (2023). FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review). Molecular Medicine Reports, 27, 34. https://doi.org/10.3892/mmr.2022.12921
MLA
Meng, X., Peng, L., Wei, X., Li, S."FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review)". Molecular Medicine Reports 27.2 (2023): 34.
Chicago
Meng, X., Peng, L., Wei, X., Li, S."FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review)". Molecular Medicine Reports 27, no. 2 (2023): 34. https://doi.org/10.3892/mmr.2022.12921
Copy and paste a formatted citation
x
Spandidos Publications style
Meng X, Peng L, Wei X and Li S: FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review). Mol Med Rep 27: 34, 2023.
APA
Meng, X., Peng, L., Wei, X., & Li, S. (2023). FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review). Molecular Medicine Reports, 27, 34. https://doi.org/10.3892/mmr.2022.12921
MLA
Meng, X., Peng, L., Wei, X., Li, S."FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review)". Molecular Medicine Reports 27.2 (2023): 34.
Chicago
Meng, X., Peng, L., Wei, X., Li, S."FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (Review)". Molecular Medicine Reports 27, no. 2 (2023): 34. https://doi.org/10.3892/mmr.2022.12921
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team